Science

Chris Collins’ Indictment Reveals Dark Side of Immunotherapy

INSIDER TRADING

MIS416 was touted as a miracle drug that could potentially cure a severe form of multiple sclerosis. But it might have been hyped up too quickly.

Tanya Basu
Tanya Basu 

Senior Editor, Science

chris collins rep new york ny immunotherapy mis416 secondary progressive multiple sclerosis spms innate australia insider trading fraud
Tom Williams/Getty
Tanya Basu

Tanya Basu

Senior Editor, Science

tanyabasu

Got a tip? Send it to The Daily Beast here.

Trending Now
PoliticsSneering Pete Hegseth Immediately Torn Apart in Confirmation Showdown
Josh Fiallo
TrumplandTrump Snubs Elon With Decision on White House Digs
Yasmeen Hamadeh
PoliticsLying Trump Took His Own Supporters for Fools: Jack Smith
Sean Craig
ElectionsMichelle Obama Is Skipping Donald Trump’s Second Inauguration
Martha Mercer,
Liam Archacki
MediaStar Washington Post Columnist Torches Bezos on Her Way Out the Door
Josh Fiallo